Tigulixostat
CAS No. 1287766-55-5
Tigulixostat( —— )
Catalog No. M35447 CAS No. 1287766-55-5
Tigulixostat (LC350189) is a novel xanthine oxidase inhibitor (XOI) that reduces uric acid production and may be used in studies of gout-related diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 258 | In Stock |
|
| 5MG | 235 | In Stock |
|
| 10MG | 376 | In Stock |
|
| 25MG | 755 | In Stock |
|
| 50MG | 1144 | In Stock |
|
| 100MG | 1841 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTigulixostat
-
NoteResearch use only, not for human use.
-
Brief DescriptionTigulixostat (LC350189) is a novel xanthine oxidase inhibitor (XOI) that reduces uric acid production and may be used in studies of gout-related diseases.
-
DescriptionTigulixostat (LC350189) is an orally active, non-purine selective xanthine oxidase inhibitor. Tigulixostat lowers the production of uric acid. Tigulixostat can be used for gout and hyperuricemia study.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetXanthine Oxidase (XAO)
-
RecptorXanthine Oxidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1287766-55-5
-
Formula Weight294.31
-
Molecular FormulaC16H14N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (339.78 mM; Ultrasonic )
-
SMILESCC(C)n1cc(C#N)c2cc(ccc12)-n1cc(cn1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Seonghae Yoon, et al. Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects. Drug Des Devel Ther. 2015 Aug 31;9:5033-49. ?
molnova catalog
related products
-
Purpurogallin
Purpurogallin is a naturally phenol extracted from the plants of Quercus spp.
-
Benzbromarone
A uricosuric agent and non-competitive inhibitor of xanthine oxidase (Ki=8.5 uM); also has potentcy for CYP2C9; also blocks calcium-activated chloride channel (CaCC) TMEM16A with IC50 of 9.97 uM in HEK293 cells.
-
Niraxostat
Niraxostat is one of the isocytosine derivatives as xanthine oxidase inhibitors.
Cart
sales@molnova.com